SCHEMBL27010065

SCHEMBL27010065

COC(=O)N1CCCC1COC(C)S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
POLB P06746 1/20 0.37
ACE P12821 3/20 0.35
KDM4E B2RXH2 1/20 0.35
F2 P00734 1/20 0.35
REN P00797 1/20 0.35
LMNA P02545 1/20 0.35
LTA4H P09960 1/20 0.35
MAPT P10636 1/20 0.35
PEPD P12955 1/20 0.35
ALOX15 P16050 1/20 0.35
PTGS1 P23219 1/20 0.35
HTR2A P28223 1/20 0.35
PTGS2 P35354 1/20 0.35
HRH1 P35367 1/20 0.35
THPO P40225 1/20 0.35
PMP22 Q01453 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACE2 Q9BYF1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23142701 0.88 RAB9A (0.39) RAB9AL3MBTL1POLBXPNPEP1TSHR
SCHEMBL792002 0.81 HDAC8 (0.44) RAB9AL3MBTL1POLBTSHRDPP4
SCHEMBL5163678 0.79 ALOX5AP (0.36) RAB9APOLBLMNAHSD17B10
SCHEMBL21165824 0.78 TSHR (0.39) RAB9APOLBMAPTTSHRCYP1A2
SCHEMBL14268216 0.78 RAB9A (0.44) RAB9AL3MBTL1POLBACEREN
SCHEMBL30821937 0.78 POLB (0.43) RAB9AL3MBTL1POLBACEKDM4E
SCHEMBL14454188 0.77 XPNPEP1 (0.42) RAB9AL3MBTL1POLBXPNPEP1TSHR
Hydrochloric Acid SCHEMBL28520246 0.76 POLB (0.42) RAB9AL3MBTL1POLBXPNPEP1TSHR
SCHEMBL12482314 0.76 POLB (0.63) RAB9AL3MBTL1POLBLMNATSHR
SCHEMBL14294016 0.76 KMT2A (0.46) RAB9AL3MBTL1POLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016937-A1 COMPOSITION CONTAINING NUCLEIC ACID MOLECULE STABLY TORAY INDUSTRIES, INC. (JP) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016937-A1 COMPOSITION CONTAINING NUCLEIC ACID MOLECULE STABLY NSUN2, POLRMT, POLN RAB9A 3499/4885L3MBTL1 1465/4885POLB 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.